Scarica l'app Stockscreener
3.40
1.19%
0.04
Precedente Chiudi:
$3.36
Aprire:
$3.4
Volume 24 ore:
395.41K
Relative Volume:
1.15
Capitalizzazione di mercato:
$168.74M
Reddito:
$230.47M
Utile/perdita netta:
$30.28M
Rapporto P/E:
5.5738
EPS:
0.61
Flusso di cassa netto:
$38.86M
1 W Prestazione:
+0.29%
1M Prestazione:
+0.00%
6M Prestazione:
+14.48%
1 anno Prestazione:
-8.11%
Intervallo 1D:
$3.335
$3.415
Intervallo di 1 settimana:
$3.335
$3.63
Portata 52W:
$2.225
$4.13
Puma Biotechnology Inc Stock (PBYI) Company Profile
Nome
Puma Biotechnology Inc
Settore
Industria
Telefono
(424) 248-6500
Indirizzo
10880 WILSHIRE BLVD., LOS ANGELES, CA
Confronta PBYI con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PBYI
Puma Biotechnology Inc
|
3.40 | 168.27M | 230.47M | 30.28M | 38.86M | 0.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Puma Biotechnology Inc Stock (PBYI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-09-28 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-06-25 | Ripresa | BofA/Merrill | Underperform |
| 2019-10-08 | Downgrade | Goldman | Neutral → Sell |
| 2019-05-10 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-05-10 | Downgrade | Citigroup | Buy → Neutral |
| 2019-01-17 | Iniziato | Leerink Partners | Mkt Perform |
| 2019-01-03 | Downgrade | Guggenheim | Buy → Neutral |
| 2018-11-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-11-02 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2018-11-02 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-17 | Iniziato | Goldman | Sell |
| 2018-05-11 | Reiterato | Stifel | Buy |
| 2017-11-10 | Reiterato | Citigroup | Buy |
| 2017-11-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-10-02 | Reiterato | Stifel | Buy |
| 2017-09-11 | Reiterato | Credit Suisse | Outperform |
| 2017-07-10 | Ripresa | Leerink Partners | Outperform |
| 2017-06-06 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-05-25 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2017-03-02 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Puma Biotechnology Inc Borsa (PBYI) Ultime notizie
Is Puma Biotechnology Inc. a good long term investmentSkyrocketing returns - Jammu Links News
What drives Puma Biotechnology Inc. stock priceSignificant capital appreciation - Autocar Professional
Puma Biotechnology Inc. Stock Analysis and ForecastMassive profits - Autocar Professional
Does Puma Biotechnology Inc. stock pay reliable dividendsFree Access to Community - Newser
What analysts say about Puma Biotechnology Inc. stockTremendous gains - Jammu Links News
how puma biotechnology inc. stock performs during market volatilityFree Stock Selection - Newser
How Puma Biotechnology Inc. stock performs during market volatilityFree Stock Selection with 300% Return - Newser
Why Puma Biotechnology Inc. stock attracts strong analyst attentionStrong Buy Recommendations - Newser
What makes Puma Biotechnology Inc. stock price move sharplySteady Income Ideas - Newser
Are Investors Undervaluing Puma Biotechnology (PBYI) Right Now? - Yahoo Finance
Puma biotechnology CFO Nougues sells $33649 in stock By Investing.com - Investing.com South Africa
Puma biotechnology CFO Nougues sells $33649 in stock - Investing.com Australia
Puma biotechnology SVP Hunt sells $27624 in stock By Investing.com - Investing.com South Africa
Puma biotechnology SVP Hunt sells $27624 in stock - Investing.com Australia
Puma Biotechnology Executives Sell Shares Amid Ongoing Company Challenges - AInvest
Why Fast-paced Mover Puma Biotech (PBYI) Is a Great Choice for Value Investors - Yahoo Finance
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Puma Biotechnology, Inc.(NasdaqGS: PBYI) dropped from Russell 2000 Growth Index - MarketScreener
Is Puma Biotechnology (PBYI) Stock Undervalued Right Now? - Yahoo Finance
Puma Biotechnology: Updated Timelines And A Resurgence In Sentiment (NASDAQ:PBYI) - Seeking Alpha
Fast-paced Momentum Stock Puma Biotech (PBYI) Is Still Trading at a Bargain - Nasdaq
Puma Biotechnology Updates Bylaws for Compliance - TipRanks
Puma Biotechnology Holds Annual Stockholders Meeting 2025 - TipRanks
Should Value Investors Buy Puma Biotechnology (PBYI) Stock? - Yahoo Finance
With 57% ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) boasts of strong institutional backing - Yahoo Finance
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Sold by Squarepoint Ops LLC - Defense World
78,653 Shares in Puma Biotechnology, Inc. (NASDAQ:PBYI) Purchased by Mackenzie Financial Corp - Defense World
Puma Biotechnology Awards Key Talent with 18,250 RSUs in Strategic Retention Move - Stock Titan
Puma Biotechnology, Inc. (NASDAQ:PBYI) Shares Fly 25% But Investors Aren't Buying For Growth - simplywall.st
Is Puma Biotechnology, Inc.'s (NASDAQ:PBYI) Latest Stock Performance A Reflection Of Its Financial Health? - simplywall.st
Puma Biotechnology Inc Azioni (PBYI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.59%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):